CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Liothyronine

碘塞罗宁 杂质对照品Liothyronine Impurities

EP31 个杂质条目31 impurity entries

本页汇总 碘塞罗宁 的 31 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 31 impurity reference standards of Liothyronine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 碘塞罗宁(Liothyronine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesImpurity profiling of liothyronine sodium by means of reversed phase HPLC, high resolution mass spectrometry, on-line H/D exchange and UV/Vis absorption
    Journal of pharmaceutical and biomedical analysis · 2017 · Ruggenthaler M et al.  ·  PMID 28599168  ·  DOI
  2. 杂质研究Impurity studiesPreclinical toxicological assessment of levothyroxine and liothyronine Maillard impurities
    Toxicology research · 2022 · Agarwal A et al.  ·  PMID 36330073  ·  DOI
  3. 杂质研究Impurity studiesReverse phase high pressure liquid chromatographic determination of some iodoamino acid contaminants in sodium liothyronine or sodium levothyroxine
    Journal - Association of Official Analytical Chemists · 1979 · Smith DJ, Graham JH  ·  PMID 500533
  4. 分析方法Analytical MethodsThe separation and determination of liothyronine and levothyroxine in tablets by reversed-phase high performance liquid chromatography
    Journal of chromatographic science · 1981 · Smith DJ et al.  ·  PMID 7228964  ·  DOI
  5. 分析方法Analytical MethodsReversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity
    Journal of pharmaceutical sciences · 1981 · Rapaka RS et al.  ·  PMID 7205213  ·  DOI

碘塞罗宁 —— 原料药与杂质对照品Liothyronine — drug substance & impurities

共 31 个条目(含原料药本体)31 items incl. the drug substance
Liothyronine Impurity 1 Sodium Salt Hydrate (Liothyronine EP Impurity A Sodium Salt Hydrate) structure
EPA
碘塞罗宁杂质1 钠盐 水合物 (碘塞罗宁EP杂质A 钠盐 水合物)Liothyronine Impurity 1 Sodium Salt Hydrate (Liothyronine EP Impurity A Sodium Salt Hydrate)
Liothyronine Impurity 1 Sodium Salt Hydrate (Liothyronine EP Impurity A Sodium Salt Hydrate)
CAS No.25416-65-3
Chemical FormulaC15H10I4NO4-·Na+·n(H2O)
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 1 (Liothyronine EP Impurity A) structure
EPA
碘塞罗宁杂质1(碘塞罗宁EP杂质A)Liothyronine Impurity 1 (Liothyronine EP Impurity A)
Liothyronine Impurity 1 (Liothyronine EP Impurity A)
CAS No.51-48-9
Chemical FormulaC15H11I4NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 2 (Liothyronine EP Impurity B) structure
EPB
碘塞罗宁杂质2(碘塞罗宁EP杂质B)Liothyronine Impurity 2 (Liothyronine EP Impurity B)
Liothyronine Impurity 2 (Liothyronine EP Impurity B)
CAS No.300-39-0
Chemical FormulaC9H9I2NO3
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 1 -13C6(Liothyronine EP Impurity A-13C6) structure
EPA-13C6
碘塞罗宁杂质1-13C6(碘塞罗宁EP杂质A-13C6)Liothyronine Impurity 1 -13C6(Liothyronine EP Impurity A-13C6)
Liothyronine Impurity 1 -13C6(Liothyronine EP Impurity A-13C6)
CAS No.1217780-14-7
Chemical FormulaC913C6H11I4NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 3-13C6 (Liothyronine EP Impurity C-13C6) structure
EPC-13C6
碘塞罗宁杂质3-13C6 (碘塞罗宁EP杂质C-13C6)Liothyronine Impurity 3-13C6 (Liothyronine EP Impurity C-13C6)
Liothyronine Impurity 3-13C6 (Liothyronine EP Impurity C-13C6)
CAS No.2455541-92-9
Chemical FormulaC813C6H9I3O4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 6 structure
6
碘塞罗宁杂质6Liothyronine Impurity 6
Liothyronine Impurity 6
CAS No.2088032-58-8
Chemical FormulaC30H23I5N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 7 structure
7
碘塞罗宁杂质7Liothyronine Impurity 7
Liothyronine Impurity 7
CAS No.1638929-80-2
Chemical FormulaC30H22I6N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 8 structure
8
碘塞罗宁杂质8Liothyronine Impurity 8
Liothyronine Impurity 8
CAS No.2088032-62-4
Chemical FormulaC30H21I7N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 9 structure
9
碘塞罗宁杂质9Liothyronine Impurity 9
Liothyronine Impurity 9
CAS No.2088032-70-4
Chemical FormulaC44H30I10N2O10
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 10 structure
10
碘塞罗宁杂质10Liothyronine Impurity 10
Liothyronine Impurity 10
CAS No.2086263-05-8
Chemical FormulaC21H15I4NO5
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 11 structure
11
碘塞罗宁杂质11Liothyronine Impurity 11
Liothyronine Impurity 11
CAS No.2086266-94-4
Chemical FormulaC28H16I7NO7
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 12 structure
12
碘塞罗宁杂质12Liothyronine Impurity 12
Liothyronine Impurity 12
CAS No.2088032-74-8
Chemical FormulaC29H17I8NO8
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 13 structure
13
碘塞罗宁杂质13Liothyronine Impurity 13
Liothyronine Impurity 13
CAS No.2088032-52-2
Chemical FormulaC16H14I4N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 14 structure
14
碘塞罗宁杂质14Liothyronine Impurity 14
Liothyronine Impurity 14
CAS No.94345-95-6
Chemical FormulaC16H15I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 15 structure
15
碘塞罗宁杂质15Liothyronine Impurity 15
Liothyronine Impurity 15
CAS No.2086260-61-7
Chemical FormulaC18H16I4N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 16 structure
16
碘塞罗宁杂质16Liothyronine Impurity 16
Liothyronine Impurity 16
CAS No.2088032-60-2
Chemical FormulaC30H23I5N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 17 structure
17
碘塞罗宁杂质17Liothyronine Impurity 17
Liothyronine Impurity 17
CAS No.2088032-54-4
Chemical FormulaC30H22I6N2O8
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 18 structure
18
碘塞罗宁杂质18Liothyronine Impurity 18
Liothyronine Impurity 18
CAS No.51-49-0
Chemical FormulaC15H11I4NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 19 structure
19
碘塞罗宁杂质19Liothyronine Impurity 19
Liothyronine Impurity 19
CAS No.31135-55-4
Chemical FormulaC15H12I3NO7S
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 21 structure
21
碘塞罗宁杂质21Liothyronine Impurity 21
Liothyronine Impurity 21
CAS No.1596-67-4
Chemical FormulaC15H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 24 structure
24
碘塞罗宁杂质24Liothyronine Impurity 24
Liothyronine Impurity 24
CAS No.403-76-9
Chemical FormulaC15H11F2I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 25 structure
25
碘塞罗宁杂质25Liothyronine Impurity 25
Liothyronine Impurity 25
CAS No.403-77-0
Chemical FormulaC15H11FI3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 26 structure
26
碘塞罗宁杂质26Liothyronine Impurity 26
Liothyronine Impurity 26
CAS No.62960-46-7
Chemical FormulaC15H11Cl2I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 27 structure
27
碘塞罗宁杂质27Liothyronine Impurity 27
Liothyronine Impurity 27
CAS No.62901-36-4
Chemical FormulaC15H11F2I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 28 structure
28
碘塞罗宁杂质28Liothyronine Impurity 28
Liothyronine Impurity 28
CAS No.7582-57-2
Chemical FormulaC15H11FI3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 29 structure
29
碘塞罗宁杂质29Liothyronine Impurity 29
Liothyronine Impurity 29
CAS No.4299-64-3
Chemical FormulaC15H11Cl2I2NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 30 structure
30
碘塞罗宁杂质30Liothyronine Impurity 30
Liothyronine Impurity 30
CAS No.1217733-23-7
Chemical FormulaC30H23I2NO6
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 31 structure
31
碘塞罗宁杂质31Liothyronine Impurity 31
Liothyronine Impurity 31
CAS No.192766-76-0
Chemical FormulaC30H22I3NO6
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 32 structure
32
碘塞罗宁杂质32Liothyronine Impurity 32
Liothyronine Impurity 32
CAS No.1174546-69-0
Chemical FormulaC15H10I4O4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 33 structure
33
碘塞罗宁杂质33Liothyronine Impurity 33
Liothyronine Impurity 33
CAS No.5714-08-9
Chemical FormulaC15H12I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Liothyronine Impurity 34 structure
34
碘塞罗宁杂质34Liothyronine Impurity 34
Liothyronine Impurity 34
CAS No.889871-36-7
Chemical FormulaC9H9ClINO3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

碘塞罗宁 —— 研究文献与合成路线Liothyronine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 碘塞罗宁 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Liothyronine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Impurity profiling of liothyronine sodium by means of reversed phase HPLC, high resolution mass spectrometry, on-line H/D exchange and UV/Vis absorption
    Ruggenthaler M, Grass J, Schuh W, et al. · Journal of pharmaceutical and biomedical analysis · 2017 · 被引 5cited 5
  2. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity
    Rapaka RS, Knight PW, Prasad VK · Journal of pharmaceutical sciences · 1981 · 被引 11cited 11

合成与制备工艺专利Synthesis & process patents

  1. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
    WALTER BURGHART, JOHANNES RANEBURGER, KURT BURGHART · 公开号 ZA200509026ZA200509026 · 2007
  2. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
    BURGHART WALTER, BURGHART KURT, RANEBURGER JOHANNES · 公开号 US2007014851US2007014851 · 2007
  3. SOLID PHARMACEUTICAL PREPARATION CONTAINING LEVOTHYROXINE AND/OR LIOTHYRONINE SALTS
    RANEBURGER JOHANNES, BURGHART KURT, BURGHART WALTER · 公开号 CA2523079CA2523079 · 2004
  4. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
    BURGHART KURT, RANEBURGER JOHANNES, BURGHART WALTER · 公开号 AU2004234176AU2004234176 · 2004
  5. SOLID PHARMACEUTICAL PREPARATION CONTAINING LEVOTHYROXINE AND/OR LIOTHYRONINE SALTS
    BURGHART Walter, BURGHART Kurt, RANEBURGER Johannes · 公开号 EP1622587EP1622587 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

碘塞罗宁 杂质谱研究要点Liothyronine — impurity profiling notes

下面这些是拿到 碘塞罗宁 的 31 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 31 impurity entries for Liothyronine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances